Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Medifirst Burn

Last content change checked dailysee data sync status

Active ingredient
Lidocaine Hydrochloride 20 g/1 L
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2013
Label revision date
September 8, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Lidocaine Hydrochloride 20 g/1 L
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2013
Label revision date
September 8, 2025
Manufacturer
Unifirst First Aid Corporation
Registration number
M015
NDC root
47682-225
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info (2 NDCs)
Packaging & NDC Codes (2)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

MEDI-FIRST Burn Spray is a specialized product designed to provide temporary pain relief for minor burns. This pump spray formulation acts as an analgesic, helping to soothe discomfort associated with burns. With a convenient 2 FL OZ (59.1 mL) size, it is easy to apply and can be washed off when needed. If you experience a minor burn, this spray can help alleviate the pain and support your healing process.

Uses

If you’re dealing with minor burns, this medication can provide temporary relief from the pain associated with those injuries. It’s specifically designed to help ease the discomfort you might feel from minor burns, allowing you to manage your symptoms more effectively.

Rest assured, this medication does not have any known teratogenic effects, meaning it does not cause harm to a developing fetus. This makes it a safer option for those who may be pregnant or planning to become pregnant.

Dosage and Administration

To use the burn spray effectively, start by cleaning the affected area thoroughly. Once it's clean, spray an even layer of the burn spray over the area. You can do this up to 3 to 4 times a day, but make sure not to exceed this limit for the best results.

It's important to note that this burn spray is not recommended for children under 12 years of age, so please avoid using it on younger individuals. Always follow these guidelines to ensure safe and effective use of the product.

What to Avoid

It's important to use this medication safely to avoid potential harm. You should not apply it in large quantities, especially on raw or blistered skin, as this can lead to irritation or other complications. Additionally, be very careful not to get the medication near your eyes. If it does come into contact with your eyes, rinse them thoroughly with water to prevent any adverse effects.

Always follow these guidelines to ensure your safety and the effectiveness of the treatment. If you have any questions or concerns, don't hesitate to reach out to your healthcare provider for more information.

Side Effects

When using this product, it's important to apply it only to the skin and avoid using large amounts, especially on raw or blistered areas. Be careful not to get it in your eyes; if that happens, rinse your eyes thoroughly with water.

If your condition worsens, lasts more than 7 days, or clears up and then comes back, you should stop using the product and consult your doctor. Additionally, keep this product out of reach of children, and if it is swallowed, seek medical help or contact a Poison Control Center immediately.

Warnings and Precautions

This product is intended for external use only, so please avoid applying it to large areas of your skin, especially if you have raw or blistered areas. Be careful not to get it near your eyes; if it does come into contact with them, rinse thoroughly with water.

If your condition worsens, does not improve after 7 days, or clears up and then returns, stop using the product and consult your doctor. Additionally, keep this product out of reach of children. If it is swallowed, seek medical help or contact a Poison Control Center immediately.

Overdose

If you or someone else has swallowed too much of a medication, it's important to act quickly. You should seek medical help or contact a Poison Control Center immediately. Signs of an overdose can vary, but they may include unusual drowsiness, confusion, or difficulty breathing.

Don't wait for symptoms to worsen; getting prompt assistance can be crucial. Always keep emergency contact numbers handy and be aware of the signs of overdose to ensure safety.

Pregnancy Use

When it comes to using Medi-First Burn Spray (lidocaine hydrochloride spray) during pregnancy, there is currently no available information about its safety, recommended dosage, or any special precautions you should take. This means that if you are pregnant or planning to become pregnant, it’s important to consult with your healthcare provider before using this product. They can help you understand any potential risks and guide you on the best options for your situation. Always prioritize your health and the health of your baby when considering any medication.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there are no statements about the product being excreted in breast milk or any associated risks for your infant. This means that, based on current information, you can use this product without concern for its effects on your milk production or your baby’s health.

Pediatric Use

It's important to know that this medication should not be used in children under 12 years of age. If you have a child in this age group, please consult your healthcare provider for alternative options that are safe and appropriate for their age. Always prioritize your child's safety and well-being when considering any medication.

Geriatric Use

When considering medication for older adults, it's important to note that this particular drug should not be used in children under 12 years of age. If you are caring for an older adult, always consult with a healthcare professional to ensure the medication is appropriate for their specific health needs and conditions. This precaution helps ensure safety and effectiveness in treatment.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment is safe and effective for your specific condition. They can help determine the best approach for managing your health, especially if you have concerns about your kidneys.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication should be used if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your liver health. They can help determine the best course of action based on your individual situation.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.

Always feel free to ask questions and share your complete list of medications and any lab tests you may be undergoing. This way, you can receive the best possible care tailored to your needs.

Storage and Handling

To ensure the best quality and safety of your product, store it at room temperature and keep it away from direct light. It's important to keep the container tightly closed when not in use to prevent contamination. Once you open the container, be sure to discard any remaining product after use to maintain safety and effectiveness. Following these guidelines will help you use the product safely and effectively.

Additional Information

You should apply the burn spray topically, which means you will spray an even layer over the cleaned affected area. This can be done no more than 3 to 4 times a day. Make sure to follow these instructions for the best results.

FAQ

What is MEDI-FIRST Burn Spray used for?

MEDI-FIRST Burn Spray is used for temporary pain relief associated with minor burns.

How should I use MEDI-FIRST Burn Spray?

You should spray an even layer of the burn spray over the cleaned affected area not more than 3-4 times daily.

Is MEDI-FIRST Burn Spray safe for children?

No, MEDI-FIRST Burn Spray is not to be used on children under 12 years of age.

Are there any side effects associated with MEDI-FIRST Burn Spray?

For external use only, do not use in large quantities, particularly over raw or blistered areas, and avoid contact with eyes.

What should I do if my condition worsens?

You should stop using the spray and ask a doctor if your condition worsens or persists for more than 7 days.

What should I do if I accidentally swallow MEDI-FIRST Burn Spray?

If swallowed, get medical help or contact a Poison Control Center right away.

Can I use MEDI-FIRST Burn Spray during pregnancy?

There is no information regarding the use of MEDI-FIRST Burn Spray during pregnancy in the provided drug insert.

Is it safe to use MEDI-FIRST Burn Spray while nursing?

There are no specific warnings or recommendations regarding the use of this product in nursing mothers.

How should I store MEDI-FIRST Burn Spray?

Store at room temperature, protect from light, and keep the container tightly closed. Discard after opening.

Packaging Info

Below are the non-prescription pack sizes of Medifirst Burn (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Medifirst Burn.
Details

Drug Information (PDF)

This file contains official product information for Medifirst Burn, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of pain associated with minor burns. It effectively alleviates pain in patients experiencing discomfort from such injuries.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to apply an even layer of the burn spray to the cleaned affected area. This application should not exceed 3 to 4 times daily.

It is important to note that this product is contraindicated for use in children under 12 years of age.

Contraindications

Use of this product is contraindicated in the following situations:

Application in large quantities, particularly over raw or blistered areas, is not recommended due to the potential for exacerbating skin irritation or damage. Additionally, the product should not be applied near the eyes; in the event of accidental contact, it is essential to rinse the area thoroughly with water to prevent irritation or injury.

Warnings and Precautions

For external use only. It is imperative that the product is not applied in large quantities, especially on raw or blistered areas, to prevent potential adverse effects. Care should be taken to avoid contact with the eyes; in the event of accidental exposure, the affected area should be rinsed thoroughly with water.

Healthcare professionals should advise patients to discontinue use and seek medical advice if the condition worsens or persists for more than 7 days, or if the symptoms resolve and then return.

Additionally, it is crucial to keep this product out of the reach of children. In the case of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware that the product is intended for external use only. It is contraindicated for use in large quantities, particularly over raw or blistered areas, and should not be applied near the eyes. In the event of contact with the eyes, it is advised to rinse thoroughly with water.

Participants are instructed to discontinue use and consult a healthcare professional if their condition worsens or persists for more than 7 days, or if the condition clears up and then returns.

Additionally, it is crucial to keep this product out of reach of children. In the case of accidental ingestion, medical assistance should be sought immediately, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Medifirst Burn (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Medifirst Burn.
Details

Pediatric Use

Pediatric patients under 12 years of age should not use this medication. Safety and efficacy have not been established in this population, and therefore, it is contraindicated for children in this age group. Healthcare professionals should consider alternative treatments for pediatric patients who fall within this age range.

Geriatric Use

Elderly patients should be considered when prescribing this medication, particularly those aged 65 years and older. It is important to note that this medication is not indicated for use in children under 12 years of age.

Healthcare providers should exercise caution when administering this medication to geriatric patients, as age-related physiological changes may affect drug metabolism and response. Close monitoring for efficacy and adverse effects is recommended in this population to ensure safety and optimal therapeutic outcomes.

Dosage adjustments may be necessary based on individual patient factors, including renal and hepatic function, which can be more variable in elderly patients. Therefore, careful assessment and ongoing evaluation are essential when treating this demographic.

Pregnancy

There is currently no information available regarding the use of Medi-First Burn Spray (lidocaine hydrochloride spray) during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when considering the use of this medication in pregnant patients. Healthcare professionals are advised to exercise caution and consider the absence of data when prescribing this medication to women of childbearing potential. It is recommended that the potential risks and benefits be carefully evaluated in the context of individual patient circumstances.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management procedures.

Healthcare providers should ensure that patients are monitored closely for any signs of toxicity and that supportive care is initiated as necessary.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are provided in the insert for MEDIFIRST BURN (lidocaine hydrochloride spray).

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help immediately or contact a Poison Control Center for assistance. It is important for patients to understand the urgency of the situation and the necessary steps to take if an accidental ingestion occurs.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. Additionally, the product must be protected from light exposure to prevent degradation.

To ensure optimal preservation, the container should be kept tightly closed when not in use. It is important to note that the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with the recommended application being an even layer of burn spray over the cleaned affected area. This should not exceed 3-4 times daily.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Medifirst Burn, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Medifirst Burn, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.